Documents | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Documents

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Document Type

  • Publication (22)
  • DEA Administrator Remarks (5)
  • Speech (2)
  • Testimony (2)

Publication Type

  • Drug Prevention (10)
  • Intelligence (10)
  • DEA Administrator (7)

Drug Name

  • Fentanyl (11)
  • Methamphetamine (10)
  • Drugs of Concern (7)
  • Heroin (7)
  • Cannabis (5)
  • Cocaine (2)
  • Synthetic Opioids (2)
  • Designer Drugs (1)
  • Hallucinogen (1)
  • Ketamine (1)
  • Spice/K2, Synthetic Marijuana (1)
  • Steroids (1)
  • Narcóticos (opioides) (23)
  • Xylazine (5)
  • Marijuana (4)

Topic

  • Family (1)
  • Self Help/Personal Growth (1)
Clear All Results
DOCUMENT

State and Territory Report on Enduring and Emerging Threats (STREET) (May edition)

Julio 23, 2024
DEA has prepared this product primarily for law enforcement counterparts (state, local and tribal) and public safety and protection officials with a focus on enduring and emerging threats at both the national and regional levels. This report represents what will be the first of regular STREET reports prepared for and...
Julio 23, 2024
DOCUMENT

Statement from DEA Administrator Anne Milgram on the Increase in DEA Fentanyl Seizures Containing Xylazine

Abril 26, 2024
DEA Administrator Remarks
WASHINGTON – DEA first warned the public of a sharp increase in fentanyl seizures containing xylazine in our March 2023 Public Safety Alert . Since that time, xylazine’s growing prevalence in the fentanyl supply continues to make the deadliest drug threat facing this country even deadlier. In 2023, 30% of...
Abril 26, 2024
DOCUMENT

State and Territory Report on Enduring and Emerging Threats (STREET)

Enero 18, 2024
Publication
DEA has prepared this product primarily for law enforcement counterparts (state, local and tribal) and public safety and protection officials with a focus on enduring and emerging threats at both the national and regional levels. This report represents what will be the first of regular STREET reports prepared for and...
Enero 18, 2024
DOCUMENT

Joint Intrepid Laboratory Releases Priority Project: Sourcing Xylazine

Octubre 19, 2023
Publication
INTREPID confirms both liquid veterinary preparations and powdered xylazine are being used to adulterate fentanyl. INTREPID observed chemical markers in xylazine seizures that can assist in determining precursors, synthetic routes, and potentially connecting cases.
Octubre 19, 2023
DOCUMENT

DEA Applauds the Repeal of the X-Waiver

Enero 17, 2023
DEA Administrator Remarks
“In this moment, when the United States is suffering tens of thousands of opioid-related drug poisoning deaths every year, the DEA’s top priority is doing everything in our power to save lives,” said Administrator Milgram. “Medication for opioid use disorder helps those who are fighting to overcome substance use disorder...
Enero 17, 2023
DOCUMENT

The Growing Threat of Xylazine and its Mixture with Illicit Drugs

Diciembre 21, 2022
Publication
Xylazine, reported as an adulterant in an increasing number of illicit drug mixtures, has also been detected in a growing number of overdose deaths. It is commonly encountered in combination with fentanyl but has also been detected in mixtures containing cocaine, heroin, and a variety of other drugs. However, xylazine...
Diciembre 21, 2022
DOCUMENT

CY 2021 Fentanyl Profiling Program (FPP)

Agosto 22, 2022
Publication
The DEA’s Fentanyl Profiling Program (FPP) performs in-depth chemical analyses on fentanyl and fentanyl-related samples obtained from seizures throughout the United States. This report summarizes the findings for these analyses for Calendar Year 2021. FPP data is not intended to reflect U.S. market share, but is rather a snapshot of...
Agosto 22, 2022
DOCUMENT

DEA Administrator's Statement on Potential Mass Fentanyl Poisoning Event in Gadsden County, Florida

Julio 02, 2022
DEA Administrator Remarks
DEA Administrator Anne Milgram's statement on a potential mass fentanyl poisoning event in Gadsden County, Florida on July 2, 2022.
Julio 02, 2022
DOCUMENT

Responding to Nationwide Increases in Fentanyl-Related Mass-Overdose Events

Abril 06, 2022
Publication
The DEA is seeing a nationwide spike in fentanyl-related mass-overdose events involving three or more overdoses occurring close in time at the same location. In just the past two months, there have been at least 7 confirmed mass overdose events across the United States resulting in 58 overdoses and 29...
Abril 06, 2022
DOCUMENT

Respuesta al Aumento Nacional de Sobredosis Masivas Relacionadas con el Fentanilo

Abril 06, 2022
Publication
La DEA está observando un repunte en todo el país de sucesos de sobredosis masivas relacionados con el fentanilo que implican tres o más sobredosis que ocurren cerca en el tiempo en el mismo lugar. Solo en los dos últimos meses, al menos 7 eventos confirmados de sobredosis masiva en...
Abril 06, 2022
Showing 1 - 10 of 32 results

Paginación

  • Current page 1
  • Página 2
  • Página 3
  • Página 4
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster